Atopic dermatitis Trials in Hellerup, Denmark
Conditions / Atopic dermatitis / Hellerup, Denmark
Atopic dermatitis is a medical condition with active clinical research programs worldwide.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03569293 | Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) | COMPLETED | PHASE3 |
| NCT05882877 | A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03160885 | Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) | COMPLETED | PHASE3 |
| NCT05601882 | A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT04114097 | The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover | COMPLETED | PHASE4 |
| NCT05651711 | A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) | COMPLETED | PHASE3 |
| NCT01949311 | Open-label Study of Dupilumab in Patients With Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT03334435 | A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT07338305 | Methotrexat to Hand Eczema in the BIOSKIN Cohort | ACTIVE_NOT_RECRUITING | — |
| NCT03903822 | Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis | COMPLETED | PHASE2 |